Short Interest in Haleon plc (NYSE:HLN) Drops By 42.9%

Haleon plc (NYSE:HLNGet Free Report) was the recipient of a large decrease in short interest during the month of August. As of August 31st, there was short interest totalling 12,630,000 shares, a decrease of 42.9% from the August 15th total of 22,130,000 shares. Based on an average daily volume of 3,570,000 shares, the short-interest ratio is presently 3.5 days. Currently, 0.3% of the company’s stock are sold short.

Haleon Stock Up 0.2 %

HLN stock traded up $0.02 during midday trading on Friday, reaching $8.27. The stock had a trading volume of 12,745,308 shares, compared to its average volume of 4,167,064. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.54 and a current ratio of 0.84. The firm has a fifty day simple moving average of $8.37 and a two-hundred day simple moving average of $8.37. Haleon has a 52-week low of $5.79 and a 52-week high of $9.05.

Haleon (NYSE:HLNGet Free Report) last announced its quarterly earnings results on Wednesday, August 2nd. The company reported $0.08 earnings per share for the quarter. The company had revenue of $3.44 billion for the quarter. On average, research analysts forecast that Haleon will post 0.45 earnings per share for the current year.

Haleon Cuts Dividend

The business also recently disclosed a — dividend, which will be paid on Thursday, October 5th. Shareholders of record on Friday, August 25th will be paid a dividend of $0.046 per share. The ex-dividend date is Thursday, August 24th. This represents a dividend yield of 1.3%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on HLN. Investec upgraded Haleon from a “sell” rating to a “hold” rating in a report on Tuesday, August 8th. Stifel Nicolaus assumed coverage on Haleon in a research note on Wednesday, May 24th. They issued a “hold” rating for the company. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Haleon currently has an average rating of “Moderate Buy” and a consensus price target of $364.00.

Check Out Our Latest Research Report on Haleon

Hedge Funds Weigh In On Haleon

A number of institutional investors have recently modified their holdings of the stock. Dodge & Cox raised its stake in shares of Haleon by 16.1% during the 1st quarter. Dodge & Cox now owns 112,055,605 shares of the company’s stock valued at $912,133,000 after buying an additional 15,545,632 shares during the last quarter. FMR LLC raised its stake in shares of Haleon by 25.8% during the 1st quarter. FMR LLC now owns 30,292,530 shares of the company’s stock valued at $246,581,000 after buying an additional 6,210,449 shares during the last quarter. Clearbridge Investments LLC raised its stake in shares of Haleon by 31.0% during the 4th quarter. Clearbridge Investments LLC now owns 25,704,881 shares of the company’s stock valued at $205,639,000 after buying an additional 6,089,500 shares during the last quarter. Harding Loevner LP increased its stake in shares of Haleon by 36.6% in the 2nd quarter. Harding Loevner LP now owns 13,260,374 shares of the company’s stock valued at $111,122,000 after purchasing an additional 3,554,361 shares in the last quarter. Finally, Bank of America Corp DE increased its stake in shares of Haleon by 31.7% in the 1st quarter. Bank of America Corp DE now owns 9,318,536 shares of the company’s stock valued at $75,853,000 after purchasing an additional 2,241,454 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Company Profile

(Get Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.

Featured Articles

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.